First results from a phase 3 study suggest the biologic agent in development could improve outcomes among people with neuromyelitis optica spectrum disorder. Medscape Medical News
Month: October 2018
Paper-Based Smart Stickers for Implantable and Stick-On Diagnostics and Therapy
Flexible electronics make possible new wearable and implantable medical devices that conform to the body’s complex curvatures. While a great deal of progress has been made to make such technologies a reality, a lot of them are hard to manufacture, suffer from problems such as poor breathability, and don’t perform well inside the body. Now […]
Smart Textiles to Release Drugs When and Where Needed
At the Swiss Federal Laboratories for Materials Science and Technology (Empa) researchers are working on integrating therapeutic drugs into textiles that can release them into the skin as needed. The researchers envision pain medication to be administered as soon as the body severely during a sports injury, or an antibiotic can be released as soon as […]
Researchers Use Novel Machine Learning Strategy to Accelerate Brain-Computer Interface Training
Brain-computer interfaces are typically systems which measure neural activity and convert it into artificial output. These systems have shown great potential for assisted movement in patients with motor impairments. The interfaces typically work by directing the patient to think about making a movement and allowing the system to repeatedly record the neural activity associated with […]
FDA, DHS coordinate medical device cybersecurity efforts
The FDA and Department of Homeland Security are stepping up efforts to protect patients from cybersecurity attacks on medical devices, according to a press release.The two agencies announced a memorandum of agreement that formalizes a “long-standing re…
Visioneering Technologies, Inc., Sponsors “The Truth about Myopia – Part 2”
ATLANTA–(BUSINESS WIRE)–VTI has sponsored an educational supplement about the growing impact of myopia on ECP practices in Contact Lens Spectrum.
Several factors may predict visual outcomes after cataract surgery in patients with retinitis pigmentosa
Preoperative best corrected visual acuity and the status of the external limiting membrane and central macular thickness may be significant predictors of postoperative visual outcomes after cataract surgery in patients with retinitis pigmentosa, accord…
Lynn Winterton, Ph.D., Pioneering Contact Lens Inventor, Named to OcuMedic, Inc. Scientific Advisory Board
MULLICA HILL, N.J.–(BUSINESS WIRE)–#Cornea–Lynn Winterton, Ph.D., Pioneering Contact Lens Inventor, Named to OcuMedic, Inc. Scientific Advisory Board
VIDEO: PTK: Uses and abuses
NEW YORK — From OSN New York 2018, Sumitra Khandelwal, MD, assistant professor of ophthalmology at Baylor College of Medicine, gives her presentation on phototherapeutic keratectomy uses and abuses.
STAAR Surgical to Report Third Quarter Results on October 31, 2018
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the th…
Glaukos Corporation to Release Third Quarter 2018 Financial Results after Market Close on November 7
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Researchers to develop new stem cell-based strategies for treating vision disorders
A team from the University of Pennsylvania, Children’s Hospital of Philadelphia, and University of Wisconsin–Madison are launching a project to develop new strategies for treating vision disorders using cells implanted in the retina.
Celebrity Plastic Surgeon & Reality Star Dr. Justin R. Johnsen Joins the WAVE Plastic Surgery Team
LOS ANGELES–(BUSINESS WIRE)–WAVE Plastic Surgery welcomes Justin R. Johnsen, MD, the first Board Certified Ophthalmologist to join the practice.
Demystifying Blockchain Technology in Healthcare: Interview with Nicholson Center CTO Dr. Roger Smith
Continuing our series of conversations with healthcare thought leaders about the burgeoning world of blockchain technologies, Medgadget spoke with Chief Technology Officer of the Nicholson Center, Dr. Roger Smith. The Nicholson Center is a medical research and training center founded in 2001, which operates within the Florida Hospital network. Dr. Smith has been researching blockchain in […]
Phase 3 trials to focus on Port Delivery System for AMD, faricimab for DME
Genentech and Roche announced the initiation of three large phase 3 clinical trials evaluating the Port Delivery System with ranibizumab to treat wet age-related macular degeneration and faricimab to treat diabetic macular edema, according to company c…
Zenni Optical Becomes First-Ever Jersey Patch Partner of the Chicago Bulls
CHICAGO–(BUSINESS WIRE)–The Chicago Bulls and Zenni Optical today announced a five-year partnership that makes the leading online eyewear company the first-ever jersey patch sponsor and the Official Eyewear Partner of the Bulls. The deal includes var…
New PICO 7Y Negative Pressure Wound Therapy System to Treat Two Sites at Once
Smith & Nephew is launching its brand new PICO 7Y negative pressure therapy system designed to be able to treat two wounds at the same time. The system uses a single pump that can support two dressings via a special Y extension, helping with cost savings while reducing the amount of gear worn by the […]
Reminder: Medgadget 2018 Sci-Fi Writing Contest: Win The Eko Digital Stethoscope
It’s that time of the year when we call on technological visionaries, medical futurists, and creative people of all kinds to submit medical science fiction stories to our annual Medgadget Sci-Fi Writing Contest. At Medgadget, we keep a record of the progress of medical technologies and hope to inspire you to imagine a future where medicine is able to […]
Kala submits NDA for topical dry eye treatment KPI-121 0.25%
A new drug application has been submitted to the FDA for KPI-121 0.25%, a topical product candidate for dry eye disease, Kala Pharmaceuticals announced in a press release.KPI-121 0.25%, which utilizes Kala’s Amplify mucus-penetrating drug delivery tech…
DMEK, DSEK have similar graft survival rates in Fuchs’ endothelial corneal dystrophy
Patients with Fuchs’ endothelial corneal dystrophy treated with either Descemet’s membrane endothelial keratoplasty or Descemet’s stripping endothelial keratoplasty experienced similar 5-year graft survival rates, according to a retrospective cohort st…